Urine CXCL10 Chemokine Monitoring Post-renal Transplant

  • End date
    Sep 25, 2022
  • participants needed
  • sponsor
    University Hospital, Basel, Switzerland
Updated on 25 January 2021
kidney transplant


In this study investigators will investigate whether early treatment of allograft rejection, as detected by urine CXCL10-monitoring, improves outcomes in renal allograft recipients.

Condition Renal Transplant Rejection
Treatment Rejection treatment according to clinical standard-of-care
Clinical Study IdentifierNCT03140514
SponsorUniversity Hospital, Basel, Switzerland
Last Modified on25 January 2021


Yes No Not Sure

Inclusion Criteria

All consenting adult (age>=18) renal allograft recipients

Exclusion Criteria

Human Leucocyte Antigen (HLA) -identical living donor transplantation
Primary non-function
Participation in immunosuppression interventional trials
Clear my responses

How to participate?

Step 1 Connect with a site
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact


Preferred Language
Other Language
Please verify that you are not a bot.

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note